π When to Suspect
Older adults (>50) with gradual or sudden central vision loss, distortion (straight lines appearing wavy, known as metamorphopsia), or a dark spot in their vision
From the full topic in The Ocean Library: Macular Degeneration
π§ When to suspect
Age-related macular degeneration (AMD) is the leading cause of certifiable sight loss in people over 65 in the UK.
β’ AMD damages the macula β the central retina responsible for sharp, detailed vision β producing central blur, distortion or a central scotoma while peripheral vision is preserved.
β’ For this reason AMD impairs reading, face recognition and driving but does not cause total blindness.
In primary care the best discriminator is tempo.
β’ Loss that is gradual over months to years points to dry (non-neovascular) AMD, for which there is no disease-specific treatment.
β’ Loss that is rapid over days to weeks, especially with new distortion of straight lines, points to wet (neovascular, active) AMD.
β’ Wet AMD is a sight-threatening but treatable condition; anti-VEGF therapy works best when started early.
So never miss wet AMD, and support the patient with dry AMD.
| Type | Typical features | Onset & primary-care action |
|---|---|---|
| Early AMD | β’ Drusen Β± pigmentary change β’ Often asymptomatic or mild blur |
β’ Gradual β’ Community optometry and risk-factor advice β do not refer asymptomatic early AMD for hospital diagnostic tests |
| Late AMD β dry | β’ Geographic atrophy of the macula β’ Progressive central scotoma |
β’ Monthsβyears β’ No disease-specific treatment β low-vision support, certification, self-monitoring |
| Late AMD β wet (active) | β’ Choroidal neovascularisation with haemorrhage or fluid β’ Rapid distortion and central loss |
Daysβweeks; URGENT referral to a macula service within 1 working day |
NICE additionally recognises late AMD (indeterminate) and late AMD (wet inactive); wet inactive AMD must not be labelled βdry AMDβ.
Raise suspicion in anyone over 50 with new central visual symptoms, and recognise the NICE risk factors:
β’ Non-modifiable: older age, AMD in the fellow eye, family history.
β’ Modifiable: smoking (the strongest modifiable factor), hypertension, BMI β₯ 30, physical inactivity, and a diet low in omega-3/6, carotenoids and vitamins or high in fat.
Source: NICE NG82
π Sign up free to see the full infographic
You're viewing a free preview. Create a free account to unlock the rest.
Sign up free βSample infographics are open to everyone in the Free Sample Bundle.